Brief: Kancera Resolves On Rights Issue Of About SEK 121.9 Mln

Novakand Pharma AB

23/02/2024 07:42

Feb 23 (Reuters) - Kancera AB  KANC.ST :
    * KANCERA RESOLVES ON A RIGHTS ISSUE OF APPROXIMATELY SEK
121.9
MILLION
    * OBJECTIVE OF RIGHTS ISSUE IS TO SECURE RESOURCES TO
ADVANCE
COMPANY'S DEVELOPMENT PROGRAM
    * RIGHTS ISSUE COMPRISES NO MORE THAN 66,223,461 SHARES
    * SUBSCRIPTION PRICE HAS BEEN SET TO SEK 1.84 PER NEW SHARE

Source text for Eikon:  ID:nMFN3HYKCT 
Further company coverage:  KANC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))